Literature DB >> 14748837

Macrophages of human first trimester decidua express markers associated to alternative activation.

Kristijan Cupurdija1, Dagmar Azzola, Ursula Hainz, Alexei Gratchev, Andreas Heitger, Osamu Takikawa, Sergij Goerdt, Reinhold Wintersteiger, Gottfried Dohr, Peter Sedlmayr.   

Abstract

PROBLEM: Depending on the type of their activation, macrophages may promote TH1- or TH2-type of immune responses. To date, not much is known about the activation phenotype of decidua macrophages, which - together with NK cells - constitute the majority of bone marrow derived cells at this location. METHOD OF STUDY: The study was based on analysis of healthy first trimester decidua by immunohistochemistry and flow cytometry. We analyzed expression of markers characteristic for alternatively activated macrophages (Mphi2).
RESULTS: The markers MS-1 (stabilin-1) and coagulation factor XIIIa were found expressed in the interior of decidua macrophages (DMphi). In contrast, indoleamine 2,3-dioxygenase (IDO), an enzyme induced in macrophages by IFNgamma, was not present in DMphi.
CONCLUSIONS: First trimester DMphi display phenotypic markers associated to alternatively activated macrophages. In addition, absence of IDO indicates that DMphi are not under a predominant influence of IFNgamma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748837     DOI: 10.1046/j.8755-8920.2003.00128.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  20 in total

1.  Selective inhibition and augmentation of alternative macrophage activation by progesterone.

Authors:  Fiona M Menzies; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

Review 3.  The role of placental tryptophan catabolism.

Authors:  Peter Sedlmayr; Astrid Blaschitz; Roland Stocker
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

4.  The immunophenotype of decidual macrophages in acute atherosis.

Authors:  Navleen Gill; Yaozhu Leng; Roberto Romero; Yi Xu; Bogdan Panaitescu; Derek Miller; Afrah Arif; Salma Mumuni; Faisal Qureshi; Chaur-Dong Hsu; Sonia S Hassan; Anne Cathrine Staff; Nardhy Gomez-Lopez
Journal:  Am J Reprod Immunol       Date:  2019-03-04       Impact factor: 3.886

Review 5.  Placental expression of indoleamine 2,3-dioxygenase.

Authors:  Peter Sedlmayr; Astrid Blaschitz
Journal:  Wien Med Wochenschr       Date:  2012-05

Review 6.  HLA class I expression in the human placenta.

Authors:  Herbert Juch; Astrid Blaschitz; Gottfried Dohr; Heinz Hutter
Journal:  Wien Med Wochenschr       Date:  2012-05

7.  Human trophoblast cells induced MDSCs from peripheral blood CD14(+) myelomonocytic cells via elevated levels of CCL2.

Authors:  Yun Zhang; Daiwei Qu; Jintang Sun; Lei Zhao; Qingjie Wang; Qianqian Shao; Beihua Kong; Yun Zhang; Xun Qu
Journal:  Cell Mol Immunol       Date:  2015-06-01       Impact factor: 11.530

8.  Differentiation of the endometrial macrophage during pregnancy in the cow.

Authors:  Lilian J Oliveira; Steve McClellan; Peter J Hansen
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

9.  Programming of human monocytes by the uteroplacental environment.

Authors:  Ramsey H McIntire; Karen G Ganacias; Joan S Hunt
Journal:  Reprod Sci       Date:  2008-05       Impact factor: 3.060

10.  HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy.

Authors:  Giada Amodio; Alessandra Mugione; Ana Maria Sanchez; Paola Viganò; Massimo Candiani; Edgardo Somigliana; Maria Grazia Roncarolo; Paola Panina-Bordignon; Silvia Gregori
Journal:  Hum Immunol       Date:  2012-12-10       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.